1. Home
  2. SMTI vs EMBC Comparison

SMTI vs EMBC Comparison

Compare SMTI & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

N/A

Current Price

$35.05

Market Cap

320.2M

Sector

Health Care

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

N/A

Current Price

$5.89

Market Cap

328.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SMTI
EMBC
Founded
1982
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
320.2M
328.1M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
SMTI
EMBC
Price
$35.05
$5.89
Analyst Decision
Hold
Hold
Analyst Count
3
4
Target Price
★ $35.00
$4.00
AVG Volume (30 Days)
154.6K
★ 898.0K
Earning Date
11-11-2026
11-24-2026
Dividend Yield
N/A
★ 0.70%
EPS Growth
N/A
★ 20.90
EPS
N/A
★ 1.03
Revenue
★ $15,586,976.00
N/A
Revenue This Year
$13.07
N/A
Revenue Next Year
$14.23
$5.59
P/E Ratio
★ N/A
$5.60
Revenue Growth
★ 32.47
N/A
52 Week Low
$16.05
$2.77
52 Week High
$35.34
$14.91

Technical Indicators

Market Signals
Indicator
SMTI
EMBC
Relative Strength Index (RSI) 63.39 61.46
Support Level $33.99 $4.84
Resistance Level $35.34 $5.91
Average True Range (ATR) 0.18 0.27
MACD -0.12 -0.01
Stochastic Oscillator 51.67 72.82

Price Performance

Historical Comparison
SMTI
EMBC

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: